Abstract

Blood and marrow transplant survivors are at risk for unique treatment related late complications and quality of life impairments. They also face challenges that limits their ability to receive appropriate patient-centric and coordinated survivorship care. Extensive research has been conducted in the field of transplant survivorship, which can serve as a model for addressing issues that cancer survivors face in general.